Encountering and Advancing Through Antiangiogenesis Therapy for Gliomas

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|15|4|353-364

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.4, 2009-02, pp. : 353-364

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Methionine aminopeptidase 2 inhibition: antiangiogenesis and tumour therapy

By Bradshaw Ralph A  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 1, 2004-01 ,pp. : 1-6

Informa Healthcare

Access to resources Recommend Favorite

Antiangiogenic Therapy for High-Grade Gliomas

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 8, Iss. 3, 2009-07 ,pp. : 184-194

Bentham Science Publishers

Access to resources Recommend Favorite

Nanoparticulate Delivery System Targeted to Tumor Neovasculature for Combined Anticancer and Antiangiogenesis Therapy

By Wang Zhe   Chui Wai-Keung   Ho Paul  

Pharmaceutical Research, Vol. 28, Iss. 3, 2011-03 ,pp. : 585-596

Springer Publishing Company

Access to resources Recommend Favorite

Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy

By Fan T.-P.D.   Jaggar R.   Bicknell R.  

Trends in Pharmacological Sciences, Vol. 16, Iss. 2, 1995-02 ,pp. : 57-66

Elsevier

Access to resources Recommend Favorite

Activin receptor-like kinase 1 as a target for anti-angiogenesis therapy

By Hawinkels Lukas JAC   Garcia de Vinuesa Amaya   ten Dijke Peter  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 11, 2013-11 ,pp. : 1371-1383

Informa Healthcare

Access to resources Recommend Favorite